Health Cor Management, L.P. Finch Therapeutics Group, Inc. Transaction History

Health Cor Management, L.P.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 16, 2021	SELL	$12.03 - $17.51 $1.8 Million - $2.63 Million	-150,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$15.54 - $21.32 $2.33 Million - $3.2 Million	150,000 New	150,000 $2.42 Million

Ticker FNCH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,688,400
Market Cap $575M
Description
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides diffi...

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Health Cor Management, L.P. with notifications on news.